ENDRA Life Sciences
NDRA
7 hedge funds and large institutions have $325K invested in ENDRA Life Sciences in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
362% more capital invested
Capital invested by funds: $70.4K → $325K (+$255K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
40% more funds holding
Funds holding: 5 → 7 (+2)
4.42% more ownership
Funds ownership: 1.74% → 6.16% (+4.4%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$296K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.8K |
| 3 |
Morgan Stanley
New York
|
+$39.6K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$23 |
| 5 |
Citigroup
New York
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$68.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.21K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$536 |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$91 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
Altium Capital Management
New York
| $235K | +$296K | +51,900 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $58.6K | +$73.8K | +12,937 | New |
|
|
3
Morgan Stanley
New York
| $31.5K | +$39.6K | +6,946 | New |
|
|
4
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $86 | -$91 | -16 | -46% |
|
|
5
UBS Group
Zurich,
Switzerland
| $54 | -$536 | -94 | -89% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $45 | +$23 | +4 | +67% |
|
|
7
Citigroup
New York
| $5 | +$6 | +1 | New |
|
|
DS
8
DRW Securities
Chicago,
Illinois
| – | -$68.4K | -12,714 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$1.21K | -225 | Closed |
|
NDRA Hedge Fund Activity: Q4 2025 in Review
7 of the 8,231 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2025, worth a combined $325K — up 362% from $70.4K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NDRA positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $296K. The largest seller was DRW Securities, exiting entirely with an estimated $68.4K sold.
- 7 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2025, up from 5 in Q3 2025.
- Funds reported $325K of ENDRA Life Sciences stock for Q4 2025, up 362% quarter-over-quarter.
- 4 funds opened new ENDRA Life Sciences positions in Q4 2025 and 2 closed out, a net change of +2 holders.
- The largest ENDRA Life Sciences buyer in Q4 2025 was Altium Capital Management, an estimated $296K added.
- The largest ENDRA Life Sciences seller in Q4 2025 was DRW Securities, an estimated $68.4K sold.
Based on aggregated 13F filings for Q4 2025.